Methyllycaconitine citrate (MLA) (S9847-GRP)

Methyllycaconitine citrate (MLA) is the citrate salt of Methyllycaconitine, a norditerpenoid alkaloid isolated from Delphinium brownii seeds. It acts as a selective antagonist of the α7 neuronal nicotinic acetylcholine receptor (α7nAChR) and exhibits potential as a drug candidate for Alzheimer’s disease treatment.